Delaware Healthcare
Compliance Guide

Delaware presents a moderately regulated, yet generally favorable, environment for healthcare companies, particularly those leveraging telehealth. The state has proactively embraced telehealth, enacting legislation to ensure parity in coverage and establishing clear guidelines for its use. Key regulatory bodies include the Delaware Board of Medical Licensure and Discipline, the Board of Nursing, and the Board of Pharmacy, all operating under the Division of Professional Regulation. The general business climate is attractive due to Delaware's robust corporate law framework, making it a popular state for entity formation, though healthcare operations must still adhere to specific state-level healthcare regulations. Recent legislative actions have primarily focused on solidifying telehealth's role post-pandemic, expanding access, and refining prescribing rules. For instance, Delaware has moved to make many pandemic-era telehealth flexibilities permanent, demonstrating a commitment to integrating virtual care into its healthcare delivery system. While not as restrictive as some states regarding the Corporate Practice of Medicine (CPOM), understanding its nuances is critical. The state emphasizes patient safety, quality of care, and appropriate licensure. Companies looking to expand into Delaware will find a clear, albeit detailed, regulatory path, especially if they prioritize establishing compliant corporate structures and adhering to specific provider scope of practice and prescribing rules. The state's approach balances innovation with patient protection, making it a viable market for various healthcare services, from traditional brick-and-mortar expansions to cutting-edge telehealth platforms. Compliance requires diligent attention to the specific statutes and regulations governing licensure, practice, and corporate structure, as outlined in the following sections.

Delaware maintains a Corporate Practice of Medicine (CPOM) doctrine, though it is not as stringently enforced or explicitly codified as in some other states. The legal basis for Delaware's CPOM doctrine primarily stems from common law principles and interpretations of the state's professional licensing statutes, particularly 24 Del. C. § 1700 et seq. (Medical Practice Act). This act reserves the practice of medicine to licensed individuals, implicitly prohibiting corporations or unlicensed individuals from employing physicians or controlling medical decisions. The core principle is that medical judgments must remain free from commercial influence. While there isn't a specific statute explicitly banning the corporate practice of medicine, the various professional practice acts, such as those for physicians, nurses, and dentists, define who can practice and under what conditions, thereby creating an implied prohibition. This means that generally, only licensed professionals or professional entities (e.g., Professional Corporations (PCs) or Professional Limited Liability Companies (PLLCs)) can directly employ other licensed professionals to provide medical services or own practices that render such services. Non-physicians are generally prohibited from owning or controlling entities that directly provide medical services. This impacts various healthcare businesses: * Telehealth Companies: Must ensure that the clinical entity providing medical services (e.g., physician consultations, prescribing) is owned and controlled by licensed medical professionals. The administrative and technological components can be housed in a separate, non-professional entity (Management Services Organization or MSO). * Medspas: Services considered the practice of medicine (e.g., injectables, laser treatments, certain IV therapies) must be performed by or under the direct supervision of a licensed physician or other authorized practitioner. The entity providing these services should ideally be physician-owned, or structured to ensure physician control over clinical decisions. * Dental Practices: Similar to medical practices, dental practices must be owned by licensed dentists. 24 Del. C. § 1100 et seq. (Dental Practice Act) governs this. * Wellness Clinics: If services offered cross into the definition of medical practice (e.g., hormone therapy, weight loss programs involving prescription medications), they fall under CPOM restrictions. Permitted ownership structures typically involve Professional Corporations (PCs) or Professional Limited Liability Companies (PLLCs) where all shareholders/members are licensed healthcare professionals. The PC-MSO model is a common compliant structure, where a physician-owned PC provides the clinical services, and a separate, non-professional MSO provides administrative, marketing, and technological support. The MSO cannot control clinical decision-making or engage in fee-splitting for professional services. Restrictions include: * Employment of Physicians: Corporations generally cannot employ physicians to practice medicine, unless it's a professional corporation. * Control over Clinical Decisions: Non-licensed individuals or entities cannot dictate or interfere with a physician's independent medical judgment. * Fee-Splitting: Prohibited if it incentivizes referrals or divides professional fees for services rendered by a licensed professional with an unlicensed entity or individual. This is addressed in the Delaware Medical Practice Act and other professional licensing statutes. Companies must structure their operations carefully to ensure the clinical entity maintains autonomy and is appropriately owned.*

Delaware has established a robust framework for telehealth, largely codified in 18 Del. C. § 3370 (Telehealth Services). This statute defines telehealth broadly and mandates coverage parity, meaning health insurers must reimburse for telehealth services at the same rate as in-person services, provided the service is medically necessary and appropriately delivered. Establishment of Provider-Patient Relationship: A provider-patient relationship can be established via telehealth in Delaware. The law does not explicitly require a prior in-person visit. However, providers must adhere to the same standards of care as if the services were provided in-person, including conducting an appropriate examination and obtaining a medical history. This implies that the initial telehealth encounter must be sufficient to establish a legitimate relationship and render a diagnosis or treatment plan. Permitted Modalities: Delaware law permits various modalities for telehealth services: * Synchronous Audio-Visual (Live Video): This is the preferred and most commonly accepted modality, allowing for real-time interactive communication. * Synchronous Audio-Only (Telephone): Permitted where appropriate and medically necessary, especially if audio-visual is not available or suitable. * Asynchronous (Store-and-Forward): Allowed for certain specialties and conditions where the transmission of medical information (e.g., images, data) for review at a later time is appropriate. * Remote Patient Monitoring (RPM): Also recognized and covered. Specific Telehealth Registration Requirements: Delaware does not impose a separate 'telehealth registration' requirement for providers already licensed in the state. However, out-of-state providers must be licensed in Delaware to provide telehealth services to patients located in Delaware, unless an exception applies (e.g., interstate compacts, emergency situations, or specific consultations). The Delaware Board of Medical Licensure and Discipline clarifies that practicing medicine in Delaware, regardless of modality, requires a Delaware license. Informed Consent Requirements: Providers must obtain informed consent from the patient before delivering telehealth services. While the specific elements of consent are not exhaustively detailed in statute, generally, it should include: * Identification of the provider and their credentials. * Confirmation that the patient understands telehealth involves the use of electronic communications. * Risks and benefits of telehealth. * Confidentiality and security measures. * Patient's right to withdraw consent. * Procedures for follow-up care and emergencies. 24 Del. C. § 1769 (Telemedicine) further states that a licensee providing telehealth services must ensure that the patient understands the services and provides informed consent. Geographic Restrictions: There are no specific geographic restrictions within Delaware for telehealth services. However, the patient must be physically located in Delaware at the time of the telehealth encounter for a Delaware-licensed provider to render services, unless the provider is licensed in the patient's state. Interstate compacts, such as the Interstate Medical Licensure Compact (IMLC), facilitate multi-state practice for eligible physicians, allowing them to obtain licenses in multiple compact states, including Delaware, more efficiently. This is crucial for telehealth companies operating across state lines.

Delaware's prescribing rules for controlled substances via telehealth largely align with federal regulations but include specific state-level nuances. The primary guiding statutes are 16 Del. C. § 4700 et seq. (Uniform Controlled Substances Act) and regulations promulgated by the Delaware Board of Medical Licensure and Discipline and the Board of Pharmacy. Controlled Substances Prescribed via Telehealth: As of 2025-2026, the federal Ryan Haight Online Pharmacy Consumer Protection Act of 2008 generally requires an in-person medical evaluation before prescribing controlled substances. However, the COVID-19 Public Health Emergency (PHE) waivers allowed for prescribing controlled substances via telehealth without a prior in-person exam. The DEA has been in the process of finalizing new rules regarding this. As of the anticipated timeframe, it is expected that a permanent framework will be in place. * Schedule II-V: Prescribing of all schedules (II-V) via telehealth is generally permitted if a legitimate provider-patient relationship has been established through an appropriate medical evaluation, which may include a telehealth encounter if it meets the standard of care. For Schedule II substances, the standard of care often implies a more rigorous initial assessment. The DEA's final rule on telehealth prescribing of controlled substances will be critical here, but Delaware's state boards typically defer to federal guidelines for this specific aspect while ensuring state standards of care are met. DEA Requirements: All prescribers of controlled substances, regardless of modality, must hold a valid DEA registration. If prescribing across state lines, the prescriber must be licensed in the state where the patient is located and registered with the DEA using an address in that state or comply with specific DEA guidance for multi-state practice. PDMP Checking Required: Yes, Delaware mandates the use of its Prescription Drug Monitoring Program (PDMP). 16 Del. C. § 4798 (Prescription Drug Monitoring Program) requires prescribers to review a patient's PDMP history before prescribing an opioid or benzodiazepine and at least every 90 days thereafter for ongoing prescriptions. This requirement applies equally to telehealth encounters. Quantity or Refill Limitations: Delaware imposes specific quantity and refill limitations for controlled substances, particularly opioids. For acute pain, initial opioid prescriptions are generally limited to a 7-day supply (16 Del. C. § 4798A). Exceptions exist for chronic pain, cancer, or palliative care, but these require specific documentation. Refills for Schedule II substances are generally prohibited, while Schedule III-V substances may have up to five refills within six months, subject to professional judgment and medical necessity. These limitations apply to telehealth prescriptions as well. Special Rules for Specific Drug Classes: * GLP-1s (e.g., Ozempic, Wegovy): While not controlled substances, prescribing GLP-1s for weight loss or diabetes management via telehealth requires a thorough medical evaluation, including patient history, physical assessment (which may be done remotely if appropriate), and ongoing monitoring. The standard of care dictates appropriate diagnosis and monitoring for potential side effects. * Testosterone: Not a controlled substance, but often subject to specific prescribing guidelines due to potential for abuse. Telehealth prescribing requires comprehensive diagnostic workup, including lab tests, and ongoing monitoring. * Stimulants (e.g., Adderall, Ritalin): Schedule II controlled substances. Prescribing via telehealth, especially for initial prescriptions, is highly scrutinized. While the PHE waivers allowed it, the long-term federal rules will dictate the necessity of an in-person exam. Delaware boards emphasize the need for a comprehensive diagnostic assessment for ADHD, including ruling out other conditions, and careful monitoring for diversion or abuse. Providers must ensure their telehealth practice model meets the highest standard of care for these medications.

Delaware's regulatory framework defines clear scopes of practice for various healthcare professionals, impacting delegation and supervision requirements. Nurse Practitioners (NPs): Delaware grants Nurse Practitioners (NPs) full practice authority, meaning they can practice independently without physician supervision or a collaborative practice agreement. This is codified in 24 Del. C. § 1900 et seq. (Nurse Practice Act) and specifically 24 Del. C. § 1902(11) defining 'Advanced Practice Registered Nurse' (APRN) and their scope. APRNs, including NPs, are authorized to diagnose, treat, and manage acute and chronic illnesses, order and interpret diagnostic tests, and prescribe medications (including controlled substances) within their specialty and competence. They must be nationally certified and licensed by the Delaware Board of Nursing. This full practice authority makes NPs highly valuable in telehealth models and independent clinics. Physician Assistants (PAs): PAs in Delaware operate under a collaborative agreement with a supervising physician, though the level of supervision has become more flexible. 24 Del. C. § 1700 et seq. (Medical Practice Act) and regulations from the Board of Medical Licensure and Discipline govern PA practice. PAs can perform medical services delegated by their supervising physician, including diagnosing, treating, and prescribing (including controlled substances). While direct, on-site supervision is not always required, the supervising physician must be readily available for consultation and review a percentage of the PA's charts. The collaborative agreement outlines the scope of practice and supervisory details. Recent changes have moved towards a 'team-based' approach, reducing some of the more rigid supervisory requirements, but the fundamental need for a collaborating physician remains. Delegation Rules for Medical Assistants (MAs) in Medspas: Medical Assistants generally have a limited scope of practice in Delaware. They can perform administrative and certain clinical tasks under the direct supervision of a physician, NP, or PA. In medspas, MAs cannot perform services that constitute the practice of medicine, such as injectables (e.g., Botox, dermal fillers), laser treatments, or deep chemical peels. These procedures must be performed by or under the direct, on-site supervision of a licensed physician, NP, or PA. Delegation to an MA for such procedures is not permissible. The Board of Medical Licensure and Discipline and the Board of Nursing issue guidance on what tasks can be delegated. For instance, an MA can prepare a patient, document vital signs, or assist with procedures, but not independently perform medical treatments. Other Mid-Level Providers: * Certified Registered Nurse Anesthetists (CRNAs): Have full practice authority in Delaware, similar to NPs, and can provide anesthesia services independently. * Certified Nurse Midwives (CNMs): Also have full practice authority for midwifery services. Supervision Requirements: * Physicians supervising PAs: Collaborative agreement required, with the supervising physician responsible for the PA's delegated medical acts. While not always on-site, the physician must be available and review charts. * Physicians/NPs/PAs supervising unlicensed personnel (e.g., MAs): Direct, on-site supervision is typically required for any tasks that involve patient care beyond basic administrative duties or where the potential for harm exists. The delegating practitioner is ultimately responsible for the actions of the supervised individual. Companies must meticulously review the specific practice acts and board regulations for each professional type to ensure compliant delegation and supervision models, especially in multi-state telehealth operations or medspa environments.

Navigating Delaware's CPOM doctrine and professional licensing requirements necessitates careful business structuring. The Professional Corporation (PC)-Management Services Organization (MSO) model is the most common and compliant structure for healthcare businesses in Delaware. PC-MSO Structures – When are they needed? The PC-MSO model is essential whenever a non-licensed individual or entity wishes to participate in the financial success of a healthcare practice that provides services falling under the definition of 'medical practice.' Since Delaware has an implied CPOM, a Professional Corporation (or PLLC) owned by licensed healthcare professionals must be the entity that directly employs the clinicians and provides the clinical services. The MSO, a separate entity typically owned by non-clinicians, provides all non-clinical, administrative, and management services to the PC. This includes billing, scheduling, marketing, IT, human resources for administrative staff, and facility management. This separation ensures that clinical decisions remain solely with the licensed professionals, while allowing for external investment and management expertise. Fee-Splitting Rules: Delaware generally prohibits fee-splitting for professional services with unlicensed individuals or entities. This is a critical consideration in MSO agreements. Payments from the PC to the MSO must be for legitimate, fair market value (FMV) administrative and management services, not a percentage of professional fees or revenue that could be construed as payment for patient referrals or a share of professional income. The MSO's compensation should ideally be a fixed fee, a cost-plus model, or a percentage of gross collections that is clearly tied to the value of services provided and not dependent on the volume or value of referrals or professional services. Violations can lead to disciplinary action against the licensed professionals and potential civil or criminal penalties. Management Services Agreement (MSA) Requirements: The MSA between the PC and the MSO is the foundational document. It must clearly delineate: * Services Provided: A detailed list of administrative and non-clinical services the MSO provides. * Compensation: The MSO's compensation structure, ensuring it is FMV and does not constitute illegal fee-splitting. * Clinical Control: Explicit affirmation that the PC retains sole control over all clinical decisions, patient care, and employment of clinical staff. * Term and Termination: Clear provisions for the agreement's duration and conditions for termination. * Compliance: Provisions requiring both parties to comply with all applicable healthcare laws and regulations. Professional Corporation (PC) Requirements: To form a Professional Corporation (or PLLC) in Delaware: * Ownership: All shareholders (or members for PLLC) must be licensed in the profession for which the entity is formed (e.g., all shareholders of a medical PC must be licensed physicians). * Purpose: The PC's sole purpose must be to render the specific professional services for which its shareholders are licensed. * Name: The corporate name must include words indicating its professional nature (e.g., 'P.A.' for Professional Association, 'P.C.' for Professional Corporation, or 'P.L.L.C.' for Professional Limited Liability Company). * Registration: Must register with the Delaware Secretary of State and comply with specific professional corporation statutes, such as 8 Del. C. § 601 et seq. How to Structure Ownership for Compliance: For telehealth companies, medspas, dental practices, and wellness clinics: * Clinical Entity: Form a Delaware Professional Corporation (PC) or Professional Limited Liability Company (PLLC) owned entirely by licensed Delaware healthcare professionals (e.g., physicians for a medical practice, dentists for a dental practice). This entity holds the necessary licenses, employs clinical staff, and provides direct patient care. * Management Entity: Form a separate Delaware LLC or C-Corp as the MSO. This entity can be owned by non-clinicians, investors, or the clinicians themselves (in a separate capacity). * Contractual Relationship: Execute a comprehensive MSA between the PC and MSO, ensuring strict adherence to fee-splitting prohibitions and clinical autonomy. This dual-entity structure is crucial for mitigating CPOM risks and attracting external investment while maintaining regulatory compliance.

Delaware continues to evolve its healthcare regulatory landscape, with several key developments and ongoing legislative considerations impacting telehealth, CPOM, and prescribing rules. Legislative Actions (2024-2026): * Telehealth Permanency: Following the COVID-19 Public Health Emergency, Delaware has largely moved to make many telehealth flexibilities permanent. While specific bill numbers vary by legislative session, the trend has been to solidify coverage parity, expand eligible services, and clarify provider requirements. Expect ongoing legislative efforts to refine definitions and address any remaining ambiguities related to out-of-state providers and specific service types. For example, bills may be introduced to further streamline interstate compact participation or clarify reimbursement for asynchronous services. * Controlled Substance Prescribing: The federal landscape for telehealth prescribing of controlled substances (Ryan Haight Act modifications) will significantly influence Delaware's approach. Delaware's Uniform Controlled Substances Act (16 Del. C. § 4700 et seq.) may see amendments or new regulations from the Board of Pharmacy or Board of Medical Licensure and Discipline to align with final DEA rules, particularly regarding the necessity of an in-person exam for initial prescriptions of Schedule II substances via telehealth. * Scope of Practice Expansions: While NPs already enjoy full practice authority, there may be legislative pushes to further expand the scope for other mid-level providers or reduce administrative burdens for PAs, aligning with national trends towards team-based care models. Recent Board Actions or Enforcement Cases: * Telehealth Compliance: Regulatory boards, particularly the Board of Medical Licensure and Discipline and the Board of Nursing, have increased scrutiny on telehealth providers to ensure adherence to the standard of care, appropriate patient evaluation, and proper documentation. Enforcement actions have primarily targeted providers operating without a Delaware license or those failing to establish a legitimate provider-patient relationship. * Medspa Oversight: There's an ongoing focus on medspas to ensure that medical procedures are performed by appropriately licensed and supervised personnel. Boards are vigilant about the unauthorized practice of medicine by unlicensed individuals and improper delegation of tasks. * Opioid Prescribing: The state continues its efforts to combat the opioid crisis, with enforcement actions against prescribers who fail to comply with PDMP requirements or exceed prescribing limits for opioids. Compact Participation Updates: * Interstate Medical Licensure Compact (IMLC): Delaware is a member of the IMLC, allowing eligible physicians licensed in a compact state to obtain expedited licensure in other compact states. This is a significant advantage for telehealth companies seeking to expand physician networks. * Nurse Licensure Compact (NLC): Delaware is also a member of the NLC, which enables registered nurses (RNs) and licensed practical nurses (LPNs) to practice in other compact states without obtaining additional licenses. This facilitates multi-state nursing practice, including for telehealth. Companies should monitor the official websites of the Delaware General Assembly, the Division of Professional Regulation, and specific licensing boards for the most up-to-date information on legislative changes and regulatory guidance.

Entering the Delaware healthcare market requires a strategic, multi-faceted approach to ensure compliance from the outset. Step-by-Step Compliance Checklist: 1. Entity Formation: Establish a Professional Corporation (PC) or Professional Limited Liability Company (PLLC) in Delaware for the clinical entity, owned by licensed professionals. Simultaneously, form a separate Delaware LLC or C-Corp for the Management Services Organization (MSO) if utilizing a PC-MSO model. 2. Licensure: Ensure all clinical providers (physicians, NPs, PAs, etc.) hold active, unrestricted Delaware licenses. For telehealth, verify patient location and provider licensure in that state. Leverage interstate compacts (IMLC, NLC) where applicable. 3. Corporate Documents: Draft and execute a robust Management Services Agreement (MSA) between the PC and MSO, ensuring fair market value compensation for the MSO and explicit clinical autonomy for the PC. Review other corporate governance documents for compliance. 4. Telehealth Protocols: Develop comprehensive telehealth policies and procedures covering: * Patient identification and authentication. * Informed consent (document and obtain). * Emergency protocols and referral pathways. * Data privacy and security (HIPAA compliance). * Documentation standards. 5. Prescribing Compliance: Implement strict protocols for controlled substance prescribing, including mandatory PDMP checks, adherence to quantity limits, and federal Ryan Haight Act compliance. Ensure appropriate evaluation for all prescriptions. 6. Scope of Practice: Clearly define and enforce the scope of practice for all clinical staff. Establish appropriate supervision and delegation protocols, especially for PAs and unlicensed personnel in medspas. 7. Billing & Reimbursement: Understand Delaware's telehealth parity laws and payer-specific requirements. Ensure accurate coding and billing practices. Common Pitfalls to Avoid: * Ignoring CPOM: Operating a clinic or telehealth service without a compliant PC-MSO structure can lead to severe penalties, including license revocation and civil fines. * Illegal Fee-Splitting: MSO compensation tied directly to a percentage of professional fees without clear justification for services rendered is a major red flag. * Unlicensed Practice: Allowing unlicensed individuals to perform medical services or providing telehealth services to Delaware residents without a Delaware license. * Inadequate Patient Evaluation: Prescribing without a sufficient medical history, physical exam (remote or in-person), or follow-up, violating the standard of care. * HIPAA Violations: Failure to protect patient health information, especially with telehealth technology. * Non-compliance with PDMP: Failing to check the PDMP before prescribing controlled substances. Timeline Expectations for Licensing and Setup: * Entity Formation: 1-2 weeks (expedited options available). * Professional Licensing: 2-4 months for new Delaware licenses, depending on the board and applicant completeness. Interstate compact licenses (IMLC, NLC) can be faster (weeks to 1-2 months). * DEA Registration: Varies, but typically 4-8 weeks after state licensure. * Payer Enrollment: Can take 3-6 months or longer, depending on the payer. * Overall Setup: Expect a minimum of 4-6 months for full operational readiness, including legal structuring, licensing, and credentialing. Proactive engagement with legal counsel specializing in Delaware healthcare law is highly recommended to navigate these complexities efficiently and compliantly.